Literature DB >> 23622328

Creutzfeldt-Jakob disease.

Thierry Billette de Villemeur1.   

Abstract

Prion diseases are rare in children. Three types are known: kuru, variant Creutzfeldt-Jakob disease (CJD), and iatrogenic CJD. All three affect children and young adults, and are transmitted by infectious contamination. Kuru was the result of ritual funeral practices similar to cannibalism; variant CJD affects young people who have eaten meat from cows with mad cow disease (mostly in the UK); and iatrogenic CJD is secondary to graft of human tissues performed in the 1980s (dura mater, pituitary extracted growth hormone). The disease appears after 4-30 years of incubation. The initial symptomatology is frequently neurological (cerebellar ataxia, oculomotor disturbance, peripheral nerve pain, pyramidal syndrome) followed by dementia. There is no biological test available that can give a definite diagnosis of prion disease apart from neuropathology, although prion accumulation in vCJD can be demonstrated in pharyngeal tonsil by immunohistochemical techniques. This devastating disease results inevitably in death. No specific treatment is available.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23622328     DOI: 10.1016/B978-0-444-52910-7.00040-4

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  3 in total

1.  Autopsy-like MRI findings: report on Creutzfeldt-Jakob disease in the end-stage.

Authors:  Simona Cammaroto; Chiara Smorto; Danilo Galletta; Placido Bramanti; Rocco Salvatore Calabrò
Journal:  Neurol Sci       Date:  2015-02-18       Impact factor: 3.307

Review 2.  Elucidating Critical Proteinopathic Mechanisms and Potential Drug Targets in Neurodegeneration.

Authors:  Khalid Bashir Dar; Aashiq Hussain Bhat; Shajrul Amin; Bilal Ahmad Reshi; Mohammad Afzal Zargar; Akbar Masood; Showkat Ahmad Ganie
Journal:  Cell Mol Neurobiol       Date:  2019-10-04       Impact factor: 5.046

Review 3.  The role of microglia in prion diseases and possible therapeutic targets: a literature review.

Authors:  Ananda Sampaio Lamenha Falcão de Melo; Juliana Louise Dias Lima; Maria Carolina Silva Malta; Natália França Marroquim; Álvaro Rivelli Moreira; Isabelle de Almeida Ladeia; Fabrizio Dos Santos Cardoso; Daniel Buzaglo Gonçalves; Bruna Guimarães Dutra; Júlio César Claudino Dos Santos
Journal:  Prion       Date:  2021-12       Impact factor: 3.931

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.